Anthropic Expands into Drug Development, Leveraging AI for Scientific Breakthroughs San Francisco-based AI company Anthropic has announced its entry into pharmaceutical research, signaling a significant shift in the application of …
Tag:
Drug Development
-
-
French biotechnology company Abivax has released updated safety data for its experimental ulcerative colitis drug, obefazimod, following concerns regarding cancer cases observed during clinical trials. The company reported that a …
-
Oral GLP-1 Receptor Agonists: Understanding the Clinical Development of Aleniglipron Aleniglipron is an experimental oral small-molecule GLP-1 receptor agonist currently under clinical investigation for the treatment of overweight and obesity. …
-
Eli Lilly Invests $40 Million in Hair Loss Startup Absci, Expanding Aesthetic Drug Portfolio Eli Lilly & Co. has invested $40 million in Absci, a biotechnology startup focused on developing …
-
Africa’s Push for Vaccine Sovereignty: Building a Self-Reliant Healthcare Future Africa currently imports roughly 99% of its vaccines and over 90% of its pharmaceutical products, creating a critical reliance on …
-
Sanofi Names Paulo Fontoura as New Global Head of R&D Sanofi, the French pharmaceutical giant, has appointed Paulo Fontoura as its new global head of research and development, effective September …
-
Health
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager phase 1 trial
Novel MAGE-A4/MAGE-A8 Bispecific T Cell Engager Shows Early Potential in Solid Tumor Trials A novel bispecific T cell engager (TCE) targeting MAGE-A4 and MAGE-A8 antigens has demonstrated early-stage safety and …
-
Patrick Soon-Shiong Faces FDA Scrutiny Over Cancer Treatment Claims, Clinical Evidence Shows Discrepancy Patrick Soon-Shiong, the billionaire physician and founder of NantWorks, has faced growing scrutiny over the claims surrounding …
-
Health
CAR T Cell Therapy for Smoldering Myeloma: Weighing Risks and Benefits in Careful Patient Selection
CAR T Cell Therapy Shows Promise and Risks for Smoldering Myeloma, Study Finds A 2023 study published in *Nature Medicine* found that CAR T cell therapy can induce deep responses …
-
Clinical Trial Begins for Lassa Fever Vaccine Candidate Researchers at the University of Maryland School of Medicine (UMSOM) have launched a Phase 1 clinical trial to evaluate the safety and …
Newer Posts